Generic numbing cream put to the test in healthy volunteers
NCT ID NCT07551713
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a generic lidocaine and prilocaine cream works the same as the brand-name EMLA® cream. Forty healthy adults had each cream applied to their thigh on separate days, and researchers measured how much of the drug got into their blood. The goal was to check bioequivalence and safety, not to see if it actually numbs better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lidocaine and prilocaine cream
- What this could lead to
- If successful, this could show that the generic cream works as well as the brand-name EMLA®, potentially offering a more affordable option for numbing skin before procedures.
- What could go wrong
- This is an early-phase study in only 40 healthy people, not patients. It only checks if the drug enters the blood similarly, not if it actually numbs better or worse in real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test